RNLX News and Press, Renalytix AI plc From 02/12/24

2024-02-12 12:47:45 ET More on Renalytix AI Seeking Alpha’s Quant Rating on Renalytix AI Historical earnings data for Renalytix AI Financial information for Renalytix AI Read the full article on Seeking Alpha For further details see: Renaly...

Electronic health record deployment of KidneyIntelX was associated with clinical actions that slowed progression of chronic kidney disease and improved Type 2 diabetes control in just 12 months Results demonstrated a 61% increase in preventative drug prescriptions among patients in the ...

2023-11-14 11:18:06 ET Renalytix Plc (RNLX) Q1 2024 Earnings Conference Call November 14, 2023 08:30 AM ET Company Participants Peter DeNardo - CapComm Partners James McCullough - Chief Executive Officer Howard Doran - Chief Business Officer Tom McLain - Pres...

2023-11-14 10:02:02 ET More on Renalytix AI Renalytix Plc (RNLX) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Renalytix AI Historical earnings data for Renalytix AI Financial information for Renalytix AI For further details ...

LONDON and SALT LAKE CITY, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, toda...

Laser Photonics Corporation (LASE) is expected to report for Q2 2024 QuickLogic Corporation (QUIK) is expected to report $0.08 for Q3 2023 Stryve Foods Inc. (SNAX) is expected to report $-1.65 for Q3 2023 Reata Pharmaceuticals Inc. (RETA) is expected to report $-2.15 for Q3 2023 V...

LONDON and SALT LAKE CITY, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that it will report its first quarter fiscal year 2024 financial results on Tuesday, November 14, 2023, before market open. The Company will host a corresponding conference call and liv...

2023-10-20 10:06:59 ET More on Health Care: Health Care Select Sector Fund ETF: Riding The Healthcare Boom September Labor Report Preview: Full Employment To Infinity Stagflation Playbook: Short Tech (QQQ/ARKK) And Long Healthcare (XLV) Stocks to watch in the...

LONDON and SALT LAKE CITY, Oct. 06, 2023 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX), the first company to commercialize an FDA authorized artificial intelligence (AI) enabled blood test to assess risk of progressive kidney function decline for individuals with type 2 diabete...

2023-10-03 08:41:53 ET Gainers: Alx Oncology ( ALXO ) +116% . Vericity  ( VERY ) +95% Strengthens Individual Insurance Presence in the United States with the Acquisition of Vericity. POINT Biopharma Global  ( PNT ) +85% to acquire Point ...